Watch BIOF. Know when insiders buy.
One email the day a filing lands. Free.
Work order
60
WATCH · insiders 45, shorts 75
Insiders, 90 days
−$91K
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $34.7MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$3.1MNET DEBT $2.4M52W 0.09 – 0.19SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$731K | −$751K | — | -0.00 | −$269K | — | — | Aug 10 |
| Q1 2026 · Mar 31 | — | — | — | −$659K | −$664K | — | -0.00 | −$419K | — | — | Aug 10 |
| Q4 2025 · Dec 31derived | — | — | — | −$1.3M | −$1.3M | — | -0.00 | −$392K | −$1 | −$392K | Mar 19 |
| Q3 2025 · Sep 30 | — | — | — | −$836K | −$423K | −122.6% | -0.00 | −$154K | −$67K | −$87K | Oct 23 |
| Q2 2025 · Jun 30 | — | — | — | −$903K | −$921K | — | -0.00 | −$312K | $32K | −$344K | Aug 10 |
| Q1 2025 · Mar 31 | — | — | — | −$689K | −$244K | — | -0.00 | $13K | $105K | −$91K | Aug 10 |
| Q4 2024 · Dec 31derived | — | — | — | −$2M | −$1.8M | — | -0.01 | −$212K | — | — | Mar 19 |
| Q3 2024 · Sep 30 | — | — | — | −$648K | $1.9M | — | 0.01 | −$248K | — | — | Oct 23 |
| Q2 2024 · Jun 30 | — | — | — | −$541K | −$549K | — | -0.00 | −$288K | — | — | Oct 23 |
| Q1 2024 · Mar 31 | — | — | — | −$904K | −$947K | — | -0.00 | −$256K | — | — | Oct 23 |
| Q4 2023 · Dec 31derived | — | — | — | −$505K | −$505K | — | -0.00 | −$106K | $6K | −$112K | Mar 19 |
| Q3 2023 · Sep 30 | — | — | — | −$513K | −$332K | — | -0.00 | −$314K | $0 | −$314K | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$3.7M | −$2.9M | — | -0.01 | −$845K | $69K | −$914K | — | — |
| FY2024 · to Dec 31 | — | — | −$4.1M | −$1.4M | — | -0.01 | −$1M | $71K | −$1.1M | — | — |
| FY2023 · to Dec 31 | — | — | −$3.2M | −$3.1M | — | -0.01 | −$1.6M | $288K | −$1.9M | — | — |
| FY2022 · to Dec 31 | — | — | −$3.9M | −$4M | — | -0.01 | −$2M | $138K | −$2.2M | — | — |
| FY2021 · to Dec 31 | — | — | −$2.2M | −$2.1M | — | -0.01 | −$2.5M | $216K | −$2.7M | — | — |
| FY2020 · to Dec 31 | — | — | −$2M | −$2.2M | — | -0.01 | −$921K | $147K | −$1.1M | — | — |
Every number comes from BLUE BIOFUELS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.